Impact of a Patient Decision Aid for Treatment of Aortic Stenosis
Primary Purpose
Aortic Valve Stenosis
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
"Treatment Choices for Aortic Stenosis" Decision Aid
Sponsored by
About this trial
This is an interventional health services research trial for Aortic Valve Stenosis focused on measuring Shared Decision Making
Eligibility Criteria
Inclusion Criteria:
- Adults 18-85 years only
- English speaking
- Severe aortic stenosis, defined as an aortic valve area < 1 cm2
- Never had AVR or who had previous AVR > 6 months previous
- Patients perceived by the clinician to be at low or intermediate risk for SAVR
Exclusion Criteria:
- Concomitant disease of another heart valve or the aorta that required either transcatheter or surgical intervention
Sites / Locations
- University of Colorado Denver I Anschutz Medical Campus
- Massachusetts General Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Usual Care
Patient Decision Aid
Arm Description
Participants will receive usual care and will not get the decision aid to review.
Participants in this arm will receive the patient decision aid, titled "Treatment Choices for Aortic Stenosis" to review.
Outcomes
Primary Outcome Measures
Knowledge score
Patients will complete 6 multiple choice knowledge items and a total knowledge score (0-100%) will be created by summing the number of correct responses and dividing by the number of items.
Secondary Outcome Measures
Shared Decision Making Process score
Items from the SDM Process survey will be summed to create a total score (0-4) with higher scores indicating more shared decision making.
Treatment Preference
Patients will indicate their preferred treatment (TAVR, surgery, or unsure)
Treatment received
Chart review will determine type of treatment received (e.g. TAVR, SAVR, other)
Full Information
NCT ID
NCT04103931
First Posted
September 24, 2019
Last Updated
December 14, 2021
Sponsor
Massachusetts General Hospital
Collaborators
University of Colorado, Denver
1. Study Identification
Unique Protocol Identification Number
NCT04103931
Brief Title
Impact of a Patient Decision Aid for Treatment of Aortic Stenosis
Official Title
Pilot Randomized Trial of a Patient Decision Aid for Treatment of Aortic Stenosis
Study Type
Interventional
2. Study Status
Record Verification Date
December 2021
Overall Recruitment Status
Completed
Study Start Date
September 23, 2019 (Actual)
Primary Completion Date
September 1, 2021 (Actual)
Study Completion Date
September 1, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Massachusetts General Hospital
Collaborators
University of Colorado, Denver
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This project will evaluate the impact of a patient decision aid created by the American College of Cardiology for patients considering treatment of aortic stenosis. The decision aid describes surgical aortic valve replacement (SAVR) surgery and transcatheter valve replacement surgery (TAVR).
Detailed Description
The pilot trial will enroll patients who are coming in to see a valve specialist (cardiac surgeon or interventional cardiologist) to discuss treatment options for aortic stenosis. The study will recruit patients at Massachusetts General Hospital or at the University of Colorado Health Heart and Vascular Center, Anschutz Medical in Denver, Colorado and randomly assign them to usual care arm or decision aid arm. The decision aid will be given to the participant in clinic at the time of their appointment. Patient participants in both arms will be asked to complete a short survey after the visit. The survey will assess knowledge, treatment preference, shared decision making (SDM), and decisional conflict. Analyses will compare the two arms on these outcomes to generate preliminary data on impact of the intervention.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aortic Valve Stenosis
Keywords
Shared Decision Making
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients are randomly assigned to receive the decision aid or usual care.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
67 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Usual Care
Arm Type
No Intervention
Arm Description
Participants will receive usual care and will not get the decision aid to review.
Arm Title
Patient Decision Aid
Arm Type
Experimental
Arm Description
Participants in this arm will receive the patient decision aid, titled "Treatment Choices for Aortic Stenosis" to review.
Intervention Type
Behavioral
Intervention Name(s)
"Treatment Choices for Aortic Stenosis" Decision Aid
Intervention Description
A decision aid, titled "Treatment Choices for Aortic Stenosis," produced by the American College of Cardiology that contains information for patients deciding between TAVR and surgery to treat their aortic stenosis.
Primary Outcome Measure Information:
Title
Knowledge score
Description
Patients will complete 6 multiple choice knowledge items and a total knowledge score (0-100%) will be created by summing the number of correct responses and dividing by the number of items.
Time Frame
About 1 week after receiving the decision aid
Secondary Outcome Measure Information:
Title
Shared Decision Making Process score
Description
Items from the SDM Process survey will be summed to create a total score (0-4) with higher scores indicating more shared decision making.
Time Frame
About 1 week after receiving the decision aid
Title
Treatment Preference
Description
Patients will indicate their preferred treatment (TAVR, surgery, or unsure)
Time Frame
About 1 week after receiving the decision aid
Title
Treatment received
Description
Chart review will determine type of treatment received (e.g. TAVR, SAVR, other)
Time Frame
12-21 weeks post visit
Other Pre-specified Outcome Measures:
Title
SURE scale
Description
The 4 item SURE scale will measure decisional conflict and the percent with the top score (4 out of 4) will be reported
Time Frame
About 1 week after receiving the decision aid
Title
CollaboRATE scale
Description
The 3 item Collaborate scale will be scored and the percent receiving the top score (27 out of 27) will be reported
Time Frame
About 1 week after the visit
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adults 18-85 years only
English speaking
Severe aortic stenosis, defined as an aortic valve area < 1 cm2
Never had AVR or who had previous AVR > 6 months previous
Patients perceived by the clinician to be at low or intermediate risk for SAVR
Exclusion Criteria:
Concomitant disease of another heart valve or the aorta that required either transcatheter or surgical intervention
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karen R Sepucha, PhD
Organizational Affiliation
Massachusetts General Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Colorado Denver I Anschutz Medical Campus
City
Aurora
State/Province
Colorado
ZIP/Postal Code
80045
Country
United States
Facility Name
Massachusetts General Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02114
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
The study team will create a complete, cleaned, de-identified copy of the final data set.
IPD Sharing Time Frame
The data will be made available to outside investigators starting 6 months after publication.
IPD Sharing Access Criteria
Information about the data sets will be on the Health Decision Sciences Center website and in publications of the data. Dr. Sepucha will share a de-identified data set with outside investigators at no cost, according to approved Massachusetts General Hospital (MGH)/ Mass General Brigham policies for data sharing. Investigators from other sites will be able to request the data and will be required to complete a data use agreement that ensures that all local Institutional Review Board (IRB) requirements are met before using the data, that they will not attempt to identify any data in the dataset, and that they will not share the data set with anyone outside their project team.
Learn more about this trial
Impact of a Patient Decision Aid for Treatment of Aortic Stenosis
We'll reach out to this number within 24 hrs